Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,040 | -18,837 | 33,820 | -53,916 | -8,233 |
| Depreciation Amortization | 9,109 | 5,833 | 2,973 | 12,927 | 9,733 |
| Accounts receivable | 641 | -73 | 722 | -1,378 | -43,845 |
| Accounts payable and accrued liabilities | -525 | -10 | 2,241 | -6,359 | -3,670 |
| Other Working Capital | 6,230 | 18,445 | 21,192 | -46,425 | -130,811 |
| Other Operating Activity | 13,611 | 10,699 | 2,364 | -46,855 | 59,447 |
| Operating Cash Flow | $2,026 | $16,057 | $63,312 | $-142,006 | $-117,379 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,722 | -4,584 | -1,059 | -9,976 | -6,090 |
| Purchase Of Investment | -202,870 | -124,468 | -24,432 | -297,251 | -200,160 |
| Sale Of Investment | 179,461 | 116,216 | 78,649 | 269,656 | 193,487 |
| Other Investing Activity | 25,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-7,131 | $-12,836 | $53,158 | $-37,571 | $-12,763 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,798 | -2,484 | -1,098 | -3,536 | -2,578 |
| Common Stock Issued | 15,516 | 7,798 | 1,685 | 163,520 | 132,704 |
| Other Financing Activity | 0 | 0 | 0 | -7,000 | -7,000 |
| Financing Cash Flow | $11,718 | $5,314 | $587 | $152,984 | $123,126 |
| Exchange Rate Effect | -159 | -25 | 30 | -109 | -43 |
| Beginning Cash Position | 12,365 | 12,365 | 12,365 | 39,067 | 39,067 |
| End Cash Position | 18,819 | 20,875 | 129,452 | 12,365 | 32,008 |
| Net Cash Flow | $6,454 | $8,510 | $117,087 | $-26,702 | $-7,059 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,026 | 16,057 | 63,312 | -142,006 | -117,379 |
| Capital Expenditure | -8,722 | -4,584 | -1,059 | -9,976 | -6,090 |
| Free Cash Flow | -6,696 | 11,473 | 62,253 | -151,982 | -123,469 |